Edition:
India

BIOLASE Inc (BIOL.OQ)

BIOL.OQ on NASDAQ Stock Exchange Capital Market

0.34USD
18 Apr 2018
Change (% chg)

-- (--)
Prev Close
$0.34
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
32,527
52-wk High
$1.42
52-wk Low
$0.30

Chart for

About

BIOLASE, Inc. (BIOLASE) is a medical device company that develops, manufactures, markets and sells laser systems in dentistry and medicine. The Company markets, sells, and distributes dental imaging equipment, including cone beam digital x-rays and computer-aided design (CAD)/computer-aided manufacturing (CAM) intra-oral... (more)

Overall

Beta: 2.42
Market Cap(Mil.): $43.30
Shares Outstanding(Mil.): 75.98
Dividend: --
Yield (%): --

Financials

BRIEF-Biolase Has Asked Jonathan Lord Chairman Of Board Of Biolase, To Lead Co's Exploration Of Strategic Alternatives

* HAS ASKED JONATHAN T. LORD CHAIRMAN OF BOARD OF BIOLASE, TO LEAD CO'S EXPLORATION OF STRATEGIC ALTERNATIVES

11 Apr 2018

BRIEF-Biolase Names Garrett Sato To Board Of Directors

* ADDITION OF SATO INCREASES SIZE OF BOARD TO FIVE DIRECTORS Source text for Eikon: Further company coverage:

05 Apr 2018

BRIEF-Biolase Reports Q4 Loss Per Share $0.05

* Q4 LOSS PER SHARE $0.05 Source text for Eikon: Further company coverage: (Reuters.Brief@thomsonreuters.com)

15 Mar 2018

BRIEF-BIOLASE Secures $6 Mln Revolving Line Of Credit

* BIOLASE SECURES $6 MILLION REVOLVING LINE OF CREDIT Source text for Eikon: Further company coverage:

07 Mar 2018

BRIEF-Biolase Announces MoU With S-Ray To Market, Sell Disruptive Radiation-Free Dental Imaging Deviceinnovative Clearview Scan Device

* BIOLASE INC - ANNOUNCES MOU WITH S-RAY TO MARKET, SELL DISRUPTIVE RADIATION-FREE DENTAL IMAGING DEVICEINNOVATIVE CLEARVIEW SCAN DEVICE Source text for Eikon: Further company coverage:

27 Feb 2018

BRIEF-Dental Corporation Signs Letter Of Intent To Buy 3 Dental Clinics ‍​

* SIGNED LETTER OF INTENT TO BUY 3 DENTAL CLINICS WITH PRICE OF ABOUT 25 MILLION BAHT - 35 MILLION BAHT ‍​ Source text for Eikon: Further company coverage:

01 Feb 2018

BRIEF-Biolase Releases Statement‍ In Response To Cao Group Litigation​

* RELEASED STATEMENT‍ IN RESPONSE TO CAO GROUP LITIGATION​ Source text for Eikon: Further company coverage:

26 Jan 2018

BRIEF-CAO Group Filed Patent Infringement Lawsuits In Court Against Biolase

* CAO GROUP INC- FILED PATENT INFRINGEMENT LAWSUITS IN UNITED STATES DISTRICT COURT AGAINST BIOLASE INC Source text for Eikon: Further company coverage:

25 Jan 2018

BRIEF-Biolase Files For Possible Resale Of Up To 21.9 Mln Shares Of Common Stock By Selling Stockholders

* BIOLASE INC FILES FOR POSSIBLE RESALE OF UP TO 21.9 MILLION SHARES OF CO'S COMMON STOCK BY SELLING STOCKHOLDERS - SEC FILING Source text - http://bit.ly/2Dj77iX Further company coverage:

17 Jan 2018

BRIEF-Dental Corporation posts qtrly ‍net profit of 12.4 mln baht

* Qtrly ‍ net profit 12.4 million baht versus 12.2 million baht Source text for Eikon: Further company coverage:

13 Nov 2017

Earnings vs. Estimates